A STING-dependent innate-sensing pathway mediates resistance to corneal HSV-1 infection via upregulation of the antiviral effector tetherin

Mucosal Immunology

Volumn 9, Issue 4, 2016, Pages 1065-1075

  Royer, D J ^a   Carr, D J J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA; PEPTIDES AND PROTEINS; SMALL INTERFERING RNA; STIMULATOR OF INTERFERON GENE PROTEIN; TETHERIN; UNCLASSIFIED DRUG; BST2 PROTEIN, MOUSE; INTERFERON; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MPYS PROTEIN, MOUSE; PATTERN RECOGNITION RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA DISEASE; CORNEA EPITHELIUM; CORNEAL HERPES SIMPLEX VIRUS 1 INFECTION; CORNEAL PACHYMETRY; ESTHESIOMETRY; FLOW CYTOMETRY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INNATE IMMUNITY; LYMPH VESSEL; MAST CELL; MOUSE; NONHUMAN; PLAQUE ASSAY; PRIORITY JOURNAL; SENSORY NERVE; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS RESISTANCE; VISUAL SYSTEM EXAMINATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CORNEA; DISEASE MODEL; GENETICS; HUMAN; HUMAN ALPHAHERPESVIRUS 1; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANIMALS; ANTIGENS, CD; CELLS, CULTURED; CORNEA; DISEASE MODELS, ANIMAL; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, PATTERN RECOGNITION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION; VIRUS REPLICATION;

EID: 84975842787     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.124     Document Type: Article

References (56)

1. Perry, A.K., Chen, G., Zheng, D., Tang, H. & Cheng, G. The host type I interferon response to viral and bacterial infections. Cell Res. 15, 407-422 (2005).
2. Ivashkiv, L.B. & Donlin, L.T. Regulation of type I interferon responses. Nat. Rev. Immunol. 14, 36-49 (2013).
3. Randall, R.E. & Goodbourn, S. Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89, 1-47 (2008).
4. Duggal, N.K. & Emerman, M. Evolutionary conflicts between viruses and restriction factors shape immunity. Nat. Rev. Immunol. 12, 687-695 (2012).
5. Barber, G.N. Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr. Opin. Immunol. 23, 10-20 (2011).
6. Rathinam, V.A.K. & Fitzgerald, K.A. Innate immune sensing of DNA viruses. Virology 411, 153-162 (2011).
7. Wu, J. & Chen, Z.J. Innate immune sensing and signaling of cytosolic nucleic acids. Annu. Rev. Immunol. 32, 461-488 (2014).
8. Conrady, C.D., Zheng, M., Fitzgerald, K.A., Liu, C. & Carr, D.J.J. Resistance to HSV-1 infection in the epithelium resides with the novel innate sensor, IFI-16. Mucosal Immunol. 5, 173-183 (2012).
9. Burdette, D.L. & Vance, R.E. STING and the innate immune response to nucleic acids in the cytosol. Nat. Immunol. 14, 19-26 (2013).
10. Tanaka, Y. & Chen, Z.J. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal. 5, ra20 (2012).
11. Unterholzner, L. et al. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11, 997-1004 (2010).
12. Orzalli, M.H., DeLuca, N.A. & Knipe, D.M. PNAS Plus: nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc. Natl. Acad. Sci. 109, E3008-E3017 (2012).
13. Lin, R., Noyce, R.S., Collins, S.E., Everett, R.D. & Mossman, K.L. The herpes simplex virus ICP0 RING finger domain inhibits IRF3-And IRF7-mediated activation of interferon-stimulated genes. J. Virol. 78, 1675-1684 (2004).
14. Paladino, P., Collins, S.E. & Mossman, K.L. Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses. PLoS One 5, e10428 (2010).
15. Royer, D.J., Cohen, A.W. & Carr, D.J. The current state of vaccine development for ocular HSV-1 infection. Expert Rev. Ophthalmol. 10, 113-126 (2015).
16. Conrady, C.D. et al. Microglia and a functional type I IFN pathway are required to counter HSV-1-driven brain lateral ventricle enlargement and encephalitis. J. Immunol. 190, 2807-2817 (2013).
17. Bonini, S., Rama, P., Olzi, D. & Lambiase, A. Neurotrophic keratitis. Eye 17, 989-995 (2003).
18. Hotter, D., Sauter, D. & Kirchhoff, F. Emerging role of the host restriction factor tetherin in viral immune sensing. J. Mol. Biol. 425, 4956-4964 (2013).
19. Li, S.X. et al. Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo. J. Immunol. 193, 306-316 (2014).
20. Sauter, D. Counteraction of the multifunctional restriction factor tetherin. Front. Microbiol. 5, 163 (2014).
21. Chucair-Elliott, A.J., Zheng, M. & Carr, D.J.J. Degeneration and regeneration of corneal nerves in response to HSV-1 infection. Invest. Ophthalmol. Vis. Sci. 56, 1097-1107 (2015).
22. Testoni, B. et al. Chromatin dynamics of gene activation and repression in response to interferon alpha (IFNa) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2. J. Biol. Chem. 286, 20217-20227 (2011).
23. Conrady, C.D., Zheng, M., Mandal, N.A., van Rooijen, N. & Carr, D.J.J. IFN-A-driven CCL2 production recruits inflammatory monocytes to infection site in mice. Mucosal Immunol. 6, 45-55 (2013).
24. Shi, C. & Pamer, E.G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11, 762-774 (2011).
25. Ishikawa, H., Ma, Z. & Barber, G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788-792 (2009).
26. Bryant-Hudson, K.M. et al. HSV-1 targets lymphatic vessels in the eye and draining lymph node ofmice leading to edema in the absence of a functional type I interferon response. Am. J. Pathol. 183, 1233-1242 (2013).
27. Wernersson, S. & Pejler, G. Mast cell secretory granules: Armed for battle. Nat. Rev. Immunol. 14, 478-494 (2014).
28. Royer, D.J., Zheng, M., Conrady, C.D. & Carr, D.J.J. Granulocytes in ocular HSV-1 infection: opposing roles of mast cells and neutrophils. Invest. Ophthalmol. Vis. Sci. 56, 3763-3775 (2015).
29. Erikson, E. et al. In vivo expression profile of the antiviral restriction factor and tumor-Targeting antigen CD317/BST-2/HM1.24/tetherin in humans. Proc. Natl. Acad. Sci. USA 108, 13688-13693 (2011).
30. Sarojini, S., Theofanis, T. & Reiss, C.S. Interferon-induced tetherin restricts vesicular stomatitis virus release in neurons. DNA Cell Biol. 30, 965-974 (2011).
31. Holmgren, A.M., Miller, K.D., Cavanaugh, S.E. & Rall, G.F. Bone marrow stromal antigen-2 (Bst2)/tetherin is induced in neurons by type I interferon and viral infection, but is dispensable for protection against neurotropic viral challenge. J. Virol. 89, 11011-11018 (2015).
32. Sarkar, J. et al. CD11b+GR1+ myeloid cells secrete NGF and promote trigeminal ganglion neurite growth: implications for corneal nerve regeneration. Invest. Ophthalmol. Vis. Sci. 54, 5920-5936 (2013).
33. Guaiquil, V.H. et al. VEGF-B selectively regenerates injured peripheral neurons and restores sensory and trophic functions. Proc. Natl. Acad. Sci. USA 111, 17272-17277 (2014).
34. Wuest, T.R. & Carr, D.J.J. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J. Exp. Med. 207, 101-115 (2010).
35. Kunder, C.A. St, John, A.L. & Abraham, S.N. Mast cell modulation of the vascular and lymphatic endothelium. Blood 118, 5383-5393 (2011).
36. Raica, M. et al. Mast cells stimulate lymphangiogenesis in the gingiva of patients with periodontal disease. In Vivo 29, 29-34 (2015).
37. Marone, G., Varricchi, G., Loffredo, S. & Granata, F. Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangiogenesis. Eur. J. Pharmacol. (2015) (doi:10.1016/j.ejphar.2015.03.088).
38. Sharma, S. et al. Suppression of systemic autoimmunity by the innate immune adaptor STING. Proc. Natl. Acad. Sci. USA 112, E710-E717 (2015).
39. Kowanetz, M. et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc. Natl. Acad. Sci. USA 107, 21248-21255 (2010).
40. Yang, X.D. et al. Histamine deficiency promotes inflammation-Associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat. Med. 17, 87-95 (2011).
41. Sceneay, J. et al. Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Res. 72, 3906-3911 (2012).
42. Seo, S.-U. et al. Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice. PLoS Pathog. 7, e1001304 (2011).
43. Gordon, S. & Taylor, P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964 (2005).
44. Strauss-Ayali, D., Conrad, S.M. & Mosser, D.M. Monocyte subpopulations and their differentiation patterns during infection. J. Leukoc. Biol. 82, 244-252 (2007).
45. Rose, S., Misharin, A. & Perlman, H. A novel Ly6C/Ly6G-based strategy to analyze the mouse splenic myeloid compartment. Cytom. A 81, 343-350 (2012).
46. Mitchell, A.J., Roediger, B. & Weninger, W. Monocyte homeostasis and the plasticity of inflammatory monocytes. Cell. Immunol. 291, 22-31 (2014).
47. Xiong, H. & Pamer, E.G. Monocytes and infection: modulator, messenger and effector. Immunobiology 220, 210-214 (2015).
48. Zhang, Z. et al. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 12, 959-965 (2011).
49. Rasmussen, S.B. et al. Activation of autophagy by a-herpesviruses in myeloid cells is mediated by cytoplasmic viral DNA through a mechanism dependent on stimulator of IFN genes. J. Immunol. 187, 5268-5276 (2011).
50. Horan, K.A. et al. Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors. J. Immunol. 190, 2311-2319 (2013).
51. Rollason, R., Korolchuk, V., Hamilton, C., Jepson, M. & Banting, G. A CD317/tetherin-RICH2 complex plays a critical role in the organization of the subapical actin cytoskeleton in polarized epithelial cells. J. Cell Biol. 184, 721-736 (2009).
52. Galao, R.P., Le Tortorec, A., Pickering, S., Kueck, T. & Neil, S.J.D. Innate sensing of HIV-1 assembly by tetherin induces NFkB-dependent proinflammatory responses. Cell Host Microbe 12, 633-644 (2012).
53. Johnson, D.C., Wisner, T.W. & Wright, C.C. Herpes simplex virus glycoproteins gB and gD function in a redundant fashion to promote secondary envelopment. J. Virol. 85, 4910-4926 (2011).
54. Martin-Serrano, J. & Neil, S.J.D. Host factors involved in retroviral budding and release. Nat. Rev. Microbiol. 9, 519-531 (2011).
55. Zenner, H.L., Mauricio, R., Banting, G. & Crump, C.M. Herpes simplex virus 1 counteracts tetherin restriction via its virion host shutoff activity. J. Virol. 87, 13115-13123 (2013).
56. Blondeau, C. et al. Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M. J. Virol. 87, 13124-13133 (2013).